Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Nephrol Dial Transplant. 2012 Feb;27(2):556-65. doi: 10.1093/ndt/gfr368. Epub 2011 Jul 12.
The number of patients with chronic kidney disease (CKD) is continuously growing worldwide. Treatment with traditional Chinese medicine might slow the progression of CKD.
In this study, we evaluated the renal protective effects of the Chinese herb Cordyceps sinensis in rats with 5/6 nephrectomy. Male Sprague-Dawley mice (weighing 150-200 g) were subjected to 5/6 nephrectomy. The rats were divided into three groups: (i) untreated nephrectomized group (OP group, n = 16), (ii) oral administration of C. sinensis-treated (4 mg/kg/day) nephrectomized group (CS group, n = 16) and (iii) sham-operated group (SO group, n = 16). The rats were sacrificed at 4 and 8 weeks after 5/6 nephrectomy, and the kidneys, serum and urine were collected for (1)H nuclear magnetic resonance spectral analysis. Multivariate statistical techniques and statistical metabolic correlation comparison analysis were performed to identify metabolic changes in aqueous kidney extracts between these groups.
Significant differences between these groups were discovered in the metabolic profiles of the biofluids and kidney extracts. Pathways including the citrate cycle, branched-chain amino acid metabolism and the metabolites that regulate permeate pressure were disturbed in the OP group compared to the SO group; in addition, these pathways were reversed by C. sinensis treatment. Biochemistry and electron microscopic images verified that C. sinensis has curative effects on chronic renal failure. These results were confirmed by metabonomics results.
Our study demonstrates that C. sinensis has potential curative effects on CKD, and our metabonomics results provided new insight into the mechanism of treatment of this traditional Chinese medicine.
全球慢性肾脏病(CKD)患者人数不断增加。中药治疗可能会减缓 CKD 的进展。
在这项研究中,我们评估了蛹虫草对 5/6 肾切除大鼠的肾脏保护作用。雄性 Sprague-Dawley 大鼠(体重 150-200g)接受 5/6 肾切除术。将大鼠分为三组:(i)未治疗肾切除组(OP 组,n=16),(ii)口服蛹虫草治疗组(4mg/kg/天)(CS 组,n=16)和(iii)假手术组(SO 组,n=16)。5/6 肾切除后 4 周和 8 周处死大鼠,采集肾脏、血清和尿液进行(1)H 核磁共振谱分析。采用多变量统计技术和统计代谢相关性比较分析,鉴定这些组之间水肾提取物的代谢变化。
在生物流体和肾提取物的代谢谱中发现这些组之间存在显著差异。与 SO 组相比,OP 组的柠檬酸循环、支链氨基酸代谢和调节渗透压的代谢物等途径发生了紊乱;此外,蛹虫草治疗逆转了这些途径。生物化学和电子显微镜图像证实蛹虫草对慢性肾衰竭有治疗作用。代谢组学结果证实了这些结果。
我们的研究表明,蛹虫草对 CKD 具有潜在的治疗作用,我们的代谢组学结果为这种中药的治疗机制提供了新的见解。